Additional File 4. MO-induced gro/tle loss of function phenotypes. Embryos at the 1-cell stage 1 were co-injected with morpholino oligonucleotides and 1 µg/ml FITC-dextran. Injections were 2 performed using either a single morpholino directed against tle1 (C), tle2b (D,F), and tle3b (E), or 3 combinations directed against tle1+2b (H), tle1+3b (I), tle2b+3b (J), and tle1+2b+3b (K). Single 4 morpholino oligonucleotides were injected at a concentration of 600 µM (C-F) and combinatorial 5 injections (H-K) were performed using 300 µM of each MO. Phenotypes of FITC-dextran positive 6 embryos were observed after the beginning of eye pigmentation at stage 32 (B-F) and stage 28 (G-K). 7 (B,G) Wild type control embryos were injected with 1x Yamamoto's and FITC-dextran. All embryos are 8 shown in dorsal view with anterior at the top. Compared to the wild type controls (B,G), morpholino 9 injected embryos developed smaller eyes that were shifted towards the midline (D,E,J,K) or cyclopic 10 eyes (C,H,I). In rare cases the eyes were lost entirely (E). (A) Phenotypes of FITC-positive embryos 11
were categorized at stage 28-32 into weak and strong phenotypes. Weak phenotypes developed 12 smaller eyes that were shifted towards the midline, whereas strong phenotypes showed cyclopic eyes. 13
Eye-less phenotypes were included into the group of strong phenotypes. Abbreviations: MO, 14 morpholino oligonucleotide; WT, wild type. Scale bar 100 µM.
